Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1:
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 20, 2012
has subject area
- 11 Medical and Health Sciences (FoR)
- Canada (MeSH)
- Drug Approval (MeSH)
- Drug Discovery (MeSH)
- Drug Industry (MeSH)
- Drugs, Generic (MeSH)
- General & Internal Medicine (Science Metrix)
- Health Policy (MeSH)
- Humans (MeSH)
- Legislation, Drug (MeSH)
- Patents as Topic (MeSH)